Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 6, 2018 $106.83 -3.93% $111.20 X 96.10% 0
Jan 16, 2018 $101.08 -1.38% $102.49 X 98.60% 1
Dec 1, 2017 $97.12 +0.83% $96.32 X 99.20% 2
Nov 30, 2017 $95.63 -1.33% $96.92 X 98.70% 1
Nov 24, 2017 $95.26 +0.57% $94.72 X 99.40% 3
Nov 21, 2017 $93.15 -1.62% $94.68 X 98.40% 0
JS JS Pro
Sep 6, 2017 $75.01 -2.65% $77.05 X 97.40% 0
Sep 6, 2017 $75.42 -2.12% $77.05 X 97.90% 0
Victor..Li.8930 Victor..Li.8930 Merchant
Jul 25, 2017 $73.35 +1.14% $72.52 X 98.90% 1
Nick Nick @Nick.3099
Jul 25, 2017 $74.15 +2.25% $72.52 X 97.80% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE